Rafarm is a contract manufacturer based in Greece. It appears in 54 regulatory filings across 9 regulators, without an active US DMF or CEP on file. Its filings concentrate with INFARMED (PT), MINSA (CR) and EFDA (ET). Its GMP standing is certified by EMA, NAFDAC (NG) and US FDA. Its most recent recorded inspection, by US FDA, closed on 21 June 2024 as VAI. Customs aggregates show $130 of exports covering 2 molecules to 1 destination in 2022.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Paiania, United Arab Emirates | Not on file |
| Paiania Attiki, United Arab Emirates | Not on file |
| LONDON, United Kingdom | Not on file |
| Paiania, Greece | Not on file |
| Greece, Greece | 3009592290 |
| Regulator | Filings | GMP certificates |
|---|---|---|
| INFARMED (PT) | 36 | None |
| MINSA (CR) | 5 | None |
| EFDA (ET) | 3 | None |
| DPM (TN) | 3 | None |
| ANPP (DZ) | 2 | None |
| ARCSA (EC) | 2 | None |
| EMA | None | 1 |
| NAFDAC (NG) | None | 1 |
| US FDA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2022 | Not reported | $130 | 1 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Rafarm comes back tiered against every other supplier able to file there.
Start for free